Kpv 5mg Reconstitution

Standard Protocol for Reconstituting KPV 5mg

To reconstitute a 5mg vial of KPV (Lys-Pro-Val) for in vitro or animal laboratory research, gently add 1.0 mL to 2.5 mL of sterile Bacteriostatic Water or Sterile Water for Injection using a sterile syringe. Direct liquid down the inner glass wall of the vial, allowing the hydrophilic lyophilized cake to dissolve naturally without vigorous shaking.

Selecting the appropriate diluent volume depends on the desired working concentration required for your assay. For example, introducing 1.0 mL of diluent to a KPV 5mg vial yields a stock concentration of 5.0 mg/mL (5,000 µg/mL). Alternatively, introducing 2.5 mL yields a working concentration of 2.0 mg/mL (2,000 µg/mL). For microfluidic assays or high-throughput screens requiring finer precision, researchers often utilize our standardized peptide reconstitution calculator to determine volumetric additions across various micromolar targets.

Step-by-Step Aseptic Laboratory Procedure

Maintaining absolute sterility during liquid handling is paramount to prevent microbial contamination and peptide degradation. Begin by sanitizing the glass vial's rubber septum with a 70% isopropyl alcohol wipe inside a certified Class II laminar flow hood or cleanroom environment. Allow the septum to air dry completely before needle insertion.

Using a sterile, single-use Luer-lock syringe fitted with a 21-to-25 gauge needle, draw the pre-calculated volume of Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Phosphate-Buffered Saline (PBS, pH 7.4). Insert the needle at a 45-degree angle through the septum to minimize rubber coring. Equalize internal vial pressure by allowing vacuum suction to gently draw the liquid, or manually control the plunger to prevent sudden pressure jets.

Once the diluent is transferred, slowly roll the vial between the palms or gently invert it 3 to 5 times. Never shake or vortex KPV vigorously, as mechanical shear stress at the air-water interface can cause peptide denaturation or aggregation. Confirm complete solubilization by inspecting the solution under direct light; high-purity KPV dissolves rapidly into a clear, colorless liquid without residual particulates.

Physicochemical Properties and Solubilization Dynamics of KPV

KPV is a short tripeptide consisting of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Derived as the C-terminal tripeptide fragment of alpha-Melanocyte-Stimulating Hormone (alpha-MSH), KPV possesses a low molecular weight of approximately 341.45 g/mol. Its structural simplicity endows it with high aqueous solubility compared to larger, highly hydrophobic oligopeptides.

The presence of a positively charged basic Lysine residue at the N-terminus renders the molecule zwitterionic and strongly hydrophilic across physiological pH ranges (pH 6.0–7.4). Consequently, KPV dissolves readily in polar solvents including sterile water, normal saline (0.9% NaCl), and standard laboratory buffers. For specialized in vitro cell culture assays, KPV can be diluted directly into culture media after initial stock reconstitution, provided osmolarity and pH parameters remain strictly controlled within the experimental setup.

Preclinical Mechanisms: Alpha-MSH Derivation and Inflammatory Pathways

In preclinical literature, KPV is classified as a non-melanotropic derivative of alpha-MSH. Unlike full-length alpha-MSH, which engages multiple melanocortin receptors (MC1R through MC5R) to induce pigmentation and steroidogenesis, the isolated tripeptide KPV demonstrates potent anti-inflammatory activity independent of classical receptor-mediated pigmentary pathways.

In vitro signaling assays indicate that KPV exerts its primary biological effects by modulating the nuclear factor kappa B (NF-κB) transcription pathway. In inflamed cell lines, KPV translocates across the cell membrane via the PepT1 transporter (SLC15A1) and directly interacts with intracellular target proteins. This internalization leads to the inhibition of IκB alpha phosphorylation, thereby preventing NF-κB activation and downstream transcription of pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6. Researchers investigating the broader family of melanocortin fragments can review detailed signaling cascades in our alpha-MSH mechanism guide.

Intestinal Barrier Function and Colitis Research Models

A major focus of KPV preclinical research involves gastrointestinal pathology, specifically epithelial barrier preservation and experimental colitis. In dextran sulfate sodium (DSS)-induced rodent models of inflammatory bowel disease (IBD), orally or parenterally administered KPV demonstrated a significant reduction in histological mucosal inflammation, myeloperoxidase (MPO) activity, and tissue necrosis.

Furthermore, in vitro studies utilizing Caco-2 intestinal epithelial cell monolayers show that KPV upregulates the expression of key tight junction proteins, including zonula occludens-1 (ZO-1) and occludin. By attenuating inflammatory cytokine-mediated barrier disruption, KPV helps maintain transepithelial electrical resistance (TEER). Scientists evaluating mucosal biology often cross-reference KPV data with findings from our larazotide acetate intestinal barrier research and general research library resources.

Comparative Analysis: KPV vs. Other Gastroprotective Compounds

When evaluating agents for intestinal inflammation and barrier repair in laboratory models, researchers frequently compare KPV against other well-studied peptides. While KPV functions predominantly through intracellular NF-κB inhibition and PepT1-mediated cellular uptake, compounds like BPC-157 5mg operate through growth factor upregulation, focal adhesion kinase activation, and nitric oxide pathway modulation.

Similarly, larazotide acetate acts as a tight junction regulator by antagonizing zonulin pathways, preventing pore opening rather than directly suppressing intracellular cytokine transcription. Meanwhile, Thymosin Beta-4 influences actin polymerization and cell migration to promote macro-tissue remodeling. Combining or contrasting these distinct mechanisms in experimental protocols allows investigators to map multi-target therapeutic pathways in preclinical mucosal biology.

Storage, Aliquoting, and Solution Stability Protocols

Lyophilized KPV powder exhibits robust chemical stability when stored in a desiccated state at -20°C or -80°C, remaining viable for up to 24 months from the date of manufacture. Protect the unconstituted vial from light exposure and temperature fluctuations to prevent slow hydrolysis or oxidized degradants.

Once reconstituted with Bacteriostatic Water, the liquid stock solution may be stored at 2°C to 8°C (refrigerated) for up to 28 days. If reconstituted with unpreserved Sterile Water or PBS, the solution must be used immediately or split into single-use aliquots and frozen at -20°C or -80°C. Repeated freeze-thaw cycles must be strictly avoided, as thermal stress induces peptide degradation. Detailed guidelines on maintaining molecular integrity across temperature regimes are available in our lyophilization storage protocols.

Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Standards

Rigorous research outcomes depend on verified chemical purity. PX1 Research subjects every batch of KPV to stringent analytical testing in ISO 17025-accredited laboratories. Purity is established using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a minimum threshold of 99.0% main-peak purity.

Molecular identity is unequivocally verified via Electrospray Ionization Mass Spectrometry (ESI-MS), confirming the theoretical mass of 341.45 Da without trace deletion or insertion sequences. Furthermore, because KPV is commonly deployed in sensitive cellular assays and animal models, every lot undergoes Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain strictly below <0.01 EU/mg. Review comprehensive batch analytical reports via our dedicated endotoxin testing reference or request lot-specific documentation prior to study initiation.

Sourcing Laboratory-Grade KPV 5mg from PX1 Research

PX1 Research is a premier USA-based supplier of high-purity research peptides, operating under strict cGMP-compliant manufacturing standards. Every KPV 5mg vial is synthesized domestically, lyophilized under inert gas, and paired with a lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms and mass spectral data.

We provide reliable distribution to academic institutions, biotechnology firms, and contract research organizations (CROs). Orders ship same-day (Monday through Friday) directly from our centralized fulfillment centers in California and Arizona. For high-volume projects, bulk screening programs, or institutional procurement accounts, visit our wholesale portal to discuss customized synthesis and volume pricing.